Summer
Senior Member
- Messages
- 175
In this video blog, Paul G. Auwaerter, MD, MBA, describes a newly published report of a potential link between a recently discovered virus and Chronic Fatigue Syndrome.
Video Blog Here
Video Blog Here
When Chronic Fatigue Syndrome Goes Undiagnosed
Can Vaccines Set Off Chronic Fatigue Syndrome?
Chronic Fatigue Syndrome Outbreaks?
Are There Two Viruses Linked With Chronic Fatigue Syndrome?
Accuracy of Current Results
In the population-based Georgia study conducted by the Centers for Disease Control and Prevention, investigators used a broader case definition and identified a population with C.F.S. that was fivefold larger than previous prevalence studies. That study may have included people with other disorders that cause fatigue, and I would expect to see up to a fivefold difference when compared with a more tightly defined group
Talk about your late bloomer: one of Canada's foremost crossword writers
only started doing crossword puzzles in her 50s.
........
But around the time she got into puzzles, chronic fatigue syndrome made
working full-time a challenge. So she moved out to Victoria in 1997 to
become a freelance writer.
-------
Job title: Crossword creator
Salary: "It's my sole source of income."
Education/training: A knowledge of puzzles and editing skills
Best Part of the Job: "I like working with words and I like the fact that
people enjoy doing my crosswords."
Worst Part of the Job: Sometimes it's tedious. The pressure of deadlines."
The scientists who gathered in Cleveland two weeks ago to share research on the retrovirus XMRV thought they would be able to convene in relative obscurity.
They were wrong.
Interest from people who suffer from chronic fatigue syndrome (CFS), and other researchers who want to study XMRV, continues to grow in the wake of the Nov. 11 meeting at the Cleveland Clinic.
"There was a lot of excitement at the meeting," Clinic cancer biologist Robert Silverman said of the gathering that drew 75 of the top scientists from 14 institutions who are studying XMRV.
For nearly 10 hours, including a break for lunch, those gathered heard 17 short talks on different facets of research. A panel discussion wrapped up the day. More informal chats stretched on into dinner at Valerio's in Little Italy (the group took over the entire restaurant).
And that's all Silverman will say for now.
"We need to keep the data presented to ourselves," he said. "It's not appropriate to present unpublished, nonpeer-reviewed data to the public.
"Every day I'm getting e-mails from scientists wanting the virus for their studies," he said.
These people are mostly virologists looking at other viruses, or researchers looking at CFS and prostate cancer, which also has been linked to XMRV.
Silverman's lab has been trying to fill requests as quickly as possible, sending the virus DNA -- not the live virus -- by mail in a test tube. (The researcher can then insert the DNA into human cells in the lab, which makes the actual virus.)
In the meantime, researchers are working to develop a diagnostic test for XMRV.
"We're working on what makes XMRV tick, how it grows and replicates, what stimulates and inhibits growth," he said.
"Patients are really intrigued," said Silverman, who said he and his colleagues have heard from CFS patients across the country. "I think this is giving them hope that there could be a treatment in the future or establish a cause. But I try to be cautious [with them]."
I had the opportunity to speak with one of the researchers who attended the Cleveland Clinic conference a short while back. Since the landmark study appeared in Science last month, several groups have been in a race to replicate the findings of Dr. Judy Mikovits - preliminary results are beginning to come in, while other researchers are waiting for their virus samples to arrive. There is now reasonable certainty that XMRV is the causal agent of CFS/ME, as opposed to probable grounds at the time of publication. It is hoped that by the middle of next year XMRV will beyond a reasonable doubt be shown to be the causal agent of ME/CFS.
Auckland GP Dr Ros Vallings will be among the first to learn how the findings can help the estimated 17 million sufferers around the world, thanks to the Cathay Pacific/Herald on Sunday High Flyers Awards. The Associated New Zealand Myalgic Encephalopathy Society will use its travel award to send Vallings to a high-powered conference in London next May.
The fifth annual ME/chronic fatigue syndrome conference will focus on the discovery of the XMRV retrovirus in blood samples from ME patients - and possible cures.
"A lot of sufferers look well, so had been mislabelled as having psychiatric conditions, and the term fatigue is very vague." Attitudes to ME in New Zealand are more advanced than in other countries such as America, where sufferers struggle to have their condition accepted as a legitimate illness, she says.
"We're quite lucky because we're a small country and it's easier to educate the powers-that-be and doctors."
Of the 101 CFS patients in the Whittemore test group, XMRV was detected in 68 of them, or 67 percent.
In addition to the 68 CFS patients who had XMRV, three other types of tests showed evidence of XMRV in another 31 people in the clinical group.
In total, 99 our of 101 people had either XMRV or showed evidence of the virus.
"This is an extraordinary number. The implications are extraordinary," said Dr. David S. Bell of Lyndonville.
Bell said if clinical trials are conducted on drugs to treat CFS, it won't happen in Lyndonville. It will have to take place at a medical research facility that would have the staff and resources to perform the studies, he said.
Bell said he'd like to see, at minimum, a satellite research clinic established in Western New York so local CFS patients could participate in the research. He suggested that CFS patients and their families contacted their Congressional delegation to lobby for research to be done in the region.